Rocket Lab president sells 15,549 shares for taxes
Rocket Lab Corp executive Marvin Bradford Clevenger, President of Rocket Lab USA, Inc, reported selling 15,549 shares of common stock on May 26, 2026.
Rhea-AI Filing Summary
Rocket Lab Corp executive Marvin Bradford Clevenger, President of Rocket Lab USA, Inc, reported selling 15,549 shares of common stock on May 26, 2026. The six open-market sales occurred at weighted-average prices between about 139 and 144 per share.
According to the disclosure, these transactions were a sell-to-cover event to satisfy tax withholding obligations triggered by the vesting and settlement of previously granted restricted stock units. The filing notes that additional shares were recently acquired under Rocket Lab’s 2021 Employee Stock Purchase Plan in exempt transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 411 | $139.4122 | $57K |
| Sale | Common Stock | 1,222 | $140.2017 | $171K |
| Sale | Common Stock | 1,519 | $141.4563 | $215K |
| Sale | Common Stock | 4,524 | $142.355 | $644K |
| Sale | Common Stock | 6,055 | $143.2433 | $867K |
| Sale | Common Stock | 1,818 | $144.1287 | $262K |
Footnotes (8)
- F1. Represents the sale of shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.
- F2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $138.7700 to $139.7600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. Includes 589 shares acquired under the Rocket Lab Corporation 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F4. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $139.8000 to $140.8000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $140.8200 to $141.8200. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $141.8300 to $142.8300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $142.8400 to $143.8300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $143.8500 to $144.7600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
sell-to-cover financial
restricted stock units financial
weighted-average price financial
Employee Stock Purchase Plan financial
Rule 16b-3(d) regulatory
FAQ
What insider transaction did Rocket Lab (RKLB) report for Marvin Bradford Clevenger?
How many separate sale transactions did the Rocket Lab (RKLB) Form 4 disclose?
AI-generated analysis. How Rhea-AI works. Not financial advice.